Friday, May 1, 2026

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

BlackRock Acquires 5.01% Stake in HLB: What This Means for Investors

BlackRock acquires a 5.01% stake in HLB, becoming the second-largest shareholder, signaling confidence in HLB's liver cancer drug.

Coupang Under Fire: Are Korean Regulations Targeting U.S. Companies Unfair?

U.S. Congress claims South Korea unfairly discriminates against American companies like Coupang amid large data breach sanctions.

Tag: good partner

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.